cerapedics

Biologics

Josh SandbergMarch 6, 2019
1,068

Cerapedics Announces ISASS Issued a new Bone Grafting Policy Statement that Features i-FACTOR™ Peptide Enhanced Bone Graft

WESTMINSTER, Colo., March 6, 2019 /PRNewswire/ –Cerapedics, a privately-held orthobiologics company, today announced that the International Society for the Advancement of Spine…
Read More »
Biologics

Josh SandbergJuly 30, 2018
1,275

Cerapedics Announces First Patients Enrolled in IDE Clinical Trial of P-15L Bone Graft for Transforaminal Lumbar Interbody Fusion Surgery

WESTMINSTER, Colo., July 30, 2018 /PRNewswire/ — Cerapedics, a privately-held orthobiologics company, today announced that the first patients have been enrolled in…
Read More »
Financial

Josh SandbergJuly 13, 2018
1,560

Cerapedics Announces Closing of $22 Million Financing

WESTMINSTER, Colo., July 13, 2018 /PRNewswire/ — Cerapedics, a privately-held orthobiologics company, today announced that the company completed a $22 million financing led by KCK…
Read More »
Biologics

Josh SandbergJune 13, 2018
1,348

Cerapedics Receives 2018 MedTech Breakthrough Award for Best New Surgical Technology Solution

WESTMINSTER, Colo., June 13, 2018 /PRNewswire/ — Cerapedics, a privately-held orthobiologics company, today announced that it has been selected as a winner…
Read More »
Biologics

Josh SandbergMay 21, 2018
1,723

Cerapedics Announces Presentation of Results from the IVANOS Study of i-FACTOR™ Peptide Enhanced Bone Graft in Uninstrumented Lumbar Posterolateral Spine Surgery

WESTMINSTER, Colo., May 21, 2018 /PRNewswire/ — Cerapedics, a privately-held orthobiologics company, today announced results from the IVANOS study evaluating i-FACTOR™ Peptide Enhanced…
Read More »
Hospitals

Josh SandbergMarch 14, 2018
1,729

Cerapedics Receives FDA IDE Approval to Initiate Study of P-15L Bone Graft for Transforaminal Lumbar Interbody Fusion Surgery

WESTMINSTER, Colo., March 14, 2018 /PRNewswire/ — Cerapedics, a privately-held orthobiologics company, today announced the company received approval from the U.S. Food…
Read More »
Biologics

Josh SandbergOctober 26, 2017
1,475

Cerapedics Announces i-FACTOR™ Peptide Enhanced Bone Graft Adopted by More than 150 Leading U.S. Hospitals

WESTMINSTER, Colo., Oct. 26, 2017 /PRNewswire/ — Cerapedics, a privately-held orthobiologics company, today announced that more than 150 leading U.S. hospitals have now…
Read More »
Biologics

DrueOctober 18, 2017
782

DSM Biomedical and Cerapedics partner for peptide enhanced bone graft

October 17, 2017 By Danielle Kirsh DSM Biomedical has partnered with Cerapedics to create and manufacture the next generation of peptide-enhanced bone graft. The partnerships…
Read More »
Biologics

DrueSeptember 12, 2017
1,008

Cerapedics Announces Publication of Two-Year IDE Study Follow-Up Data on i-FACTOR™ Bone Graft in the Cervical Spine

WESTMINSTER, Colo., Sept. 12, 2017 /PRNewswire/ — Cerapedics, a privately-held orthobiologics company, today announced the publication of two-year follow-up data from an FDA…
Read More »
Biologics

Josh SandbergNovember 30, 2016
1,108

Cerapedics Announces Breakthrough Technology Agreement with Premier Inc.

WESTMINSTER, Colo., Nov. 30, 2016 /PRNewswire/ — Cerapedics, a privately-held orthobiologics company, today announced the company has been awarded a group purchasing agreement…
Read More »
Biologics

Josh SandbergNovember 18, 2016
1,054

Cerapedics Receives Best New Technology Award for Spine Care at NASS Annual Meeting

WESTMINSTER, Colo., Nov. 18, 2016 /PRNewswire/ — Cerapedics, a privately-held orthobiologics company, today announced it has received a Best New Technology Award for…
Read More »
Biologics

Josh SandbergSeptember 29, 2016
993

Cerapedics Announces Closing of Series D Financing

WESTMINSTER, Colo., Sept. 29, 2016 /PRNewswire/ — Cerapedics, a privately-held orthobiologics company, today announced the company completed an $11 million Series D financing. The funds…
Read More »
Hospitals

Josh SandbergNovember 5, 2015
1,800

Cerapedics Receives FDA Approval for i-FACTOR™ Peptide Enhanced Bone Graft in Cervical Spine Surgery

WESTMINSTER, Colo., Nov. 3, 2015 /PRNewswire/ — Cerapedics, a privately-held orthobiologics company, announced today the U.S. Food and Drug Administration (FDA) has approved…
Read More »
Biologics

Josh SandbergFebruary 9, 2015
1,055

Cerapedics uses silk from a moth to create new spine bone graft

Biloine W. Young • Thu, February 5th, 2015 Cerapedics, Inc., a privately-held orthobiologics company located in Westminster, Colorado, has received…
Read More »
Josh SandbergApril 14, 2014
750

Cerapedics Announces Closing of Venture Debt Loan from GE Capital

WESTMINSTER, Colo., April 14, 2014 /PRNewswire/ — Cerapedics, an orthobiologics company focused on developing and commercializing its proprietary synthetic small peptide (P-15)…
Read More »